Physician profile
Christopher Serrone
NPI 1366830945
$1,003.80
in general payments reported to CMS, 2019-2025
20 companies · $70.02 in 2025
The $70.02 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $288 · 2022: $380 · 2023: $265 · 2025: $70.02.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $315 · Entertainment: $20.46.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $314.93 |
| Entertainment | $20.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $130.00 | 2021-2023 | Freestyle Libre 3 |
| Abbvie INC. | $125.50 | 2021-2022 | |
| Gilead Sciences, INC. | $113.99 | 2021-2025 | Biktarvy |
| Lilly USA, LLC | $107.60 | 2021-2023 | Mounjaro |
| Novo Nordisk INC | $89.04 | 2021-2023 | Ozempic, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $60.65 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $59.84 | 2022-2023 | Farxiga |
| Idorsia Pharmaceuticals US INC | $54.83 | 2022-2023 | Quviviq |
| Glaxosmithkline, LLC. | $46.13 | 2021-2023 | Shingrix |
| Merck Sharp & Dohme LLC | $33.69 | 2025 | Pifeltro |
| Nevro Corp. | $29.98 | 2023 | Senza |
| Dexcom, INC. | $23.79 | 2023 | Dexcom G6 Transmitter |
| Antares Pharma, INC. | $20.85 | 2023 | Nocdurna, Tlando, Xyosted |
| Ipsen Biopharmaceuticals, INC | $20.55 | 2025 | Bylvay |
| Optos, INC. | $20.46 | 2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $18.28 | 2021 | |
| Impulse Dynamics (USA) INC. | $15.50 | 2023 | Optimizer |
| Bardy Diagnostics, INC. | $12.37 | 2022 | |
| Medtronic, INC. | $12.18 | 2022 | |
| Itamar Medical INC | $8.57 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Serrone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.